These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15338857)

  • 1. Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate.
    Guo Y; Fung HB
    Pharmacotherapy; 2004 Aug; 24(8):1089-94. PubMed ID: 15338857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine.
    Murphy MD; O'Hearn M; Chou S
    Clin Infect Dis; 2003 Apr; 36(8):1082-5. PubMed ID: 12684925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
    Antoniou T; Park-Wyllie LY; Tseng AL
    Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.
    Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
    Int J STD AIDS; 2005 Sep; 16(9):646-8. PubMed ID: 16176639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
    Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
    J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
    Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
    Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
    Hawkins T; Veikley W; Durand-Gasselin L; Babusis D; Reddy YS; Flaherty JF; Ray AS
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1549-55. PubMed ID: 21282432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tenofovir on didanosine absorption in patients with HIV.
    Pecora Fulco P; Kirian MA
    Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.
    Hazra R; Balis FM; Tullio AN; DeCarlo E; Worrell CJ; Steinberg SM; Flaherty JF; Yale K; Poblenz M; Kearney BP; Zhong L; Coakley DF; Blanche S; Bresson JL; Zuckerman JA; Zeichner SL
    Antimicrob Agents Chemother; 2004 Jan; 48(1):124-9. PubMed ID: 14693529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
    Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
    Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir disoproxil fumarate.
    Chapman T; McGavin J; Noble S
    Drugs; 2003; 63(15):1597-608. PubMed ID: 12887265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.
    Butt AA
    AIDS Read; 2003 Jul; 13(7):344-8. PubMed ID: 12889452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
    Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
    JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
    Claas GJ; Jülg B; Goebel FD; Bogner J
    Eur J Med Res; 2007 Feb; 12(2):54-60. PubMed ID: 17369118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug points: Fatal lactic acidosis associated with tenofovir.
    Rivas P; Polo J; de Górgolas M; Fernández-Guerrero ML
    BMJ; 2003 Sep; 327(7417):711. PubMed ID: 14512477
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal lactic acidosis in a patient infected by HIV and treated with stavudine and didanosine].
    Mégarbane B; Goldgran-Tolédano D; Guérin JM; Baud F
    Pathol Biol (Paris); 2000 Jun; 48(5):505-7. PubMed ID: 10949849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir.
    Hansen AB; Mathiesen S; Gerstoft J
    Scand J Infect Dis; 2004; 36(5):389-92. PubMed ID: 15287389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient.
    Isoda A; Mihara M; Matsumoto M; Sawamura M
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37923339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.
    Taburet AM; Piketty C; Chazallon C; Vincent I; Gérard L; Calvez V; Clavel F; Aboulker JP; Girard PM
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2091-6. PubMed ID: 15155205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
    Squires K; Pozniak AL; Pierone G; Steinhart CR; Berger D; Bellos NC; Becker SL; Wulfsohn M; Miller MD; Toole JJ; Coakley DF; Cheng A;
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):313-20. PubMed ID: 12965939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.